UnitedHealth Group Inc (NYSE:UNH) Director Richard T. Burke sold 10,000 shares of the firm’s stock in a transaction dated Monday, March 19th. The stock was sold at an average price of $224.36, for a total transaction of $2,243,600.00. Following the transaction, the director now directly owns 1,771,257 shares of the company’s stock, valued at $397,399,220.52. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.
UnitedHealth Group Inc (NYSE UNH) opened at $215.21 on Friday. UnitedHealth Group Inc has a 1-year low of $162.74 and a 1-year high of $250.79. The stock has a market cap of $219,446.59, a PE ratio of 20.09, a P/E/G ratio of 1.32 and a beta of 0.74. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.58.
UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.50 by $0.09. UnitedHealth Group had a net margin of 5.25% and a return on equity of 21.29%. The company had revenue of $52.06 billion during the quarter, compared to the consensus estimate of $51.57 billion. During the same period in the previous year, the firm posted $2.11 earnings per share. The company’s revenue was up 9.5% on a year-over-year basis. equities analysts predict that UnitedHealth Group Inc will post 12.51 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which was paid on Tuesday, March 20th. Shareholders of record on Friday, March 9th were paid a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.39%. The ex-dividend date was Thursday, March 8th. UnitedHealth Group’s dividend payout ratio is presently 28.01%.
Several hedge funds and other institutional investors have recently made changes to their positions in the business. BlackRock Inc. raised its stake in shares of UnitedHealth Group by 1.2% in the second quarter. BlackRock Inc. now owns 69,430,416 shares of the healthcare conglomerate’s stock worth $12,873,786,000 after acquiring an additional 796,654 shares during the last quarter. Vanguard Group Inc. raised its stake in shares of UnitedHealth Group by 2.5% in the second quarter. Vanguard Group Inc. now owns 64,578,618 shares of the healthcare conglomerate’s stock worth $11,974,168,000 after acquiring an additional 1,588,516 shares during the last quarter. FMR LLC raised its stake in shares of UnitedHealth Group by 2.1% in the second quarter. FMR LLC now owns 56,101,668 shares of the healthcare conglomerate’s stock worth $10,402,371,000 after acquiring an additional 1,168,324 shares during the last quarter. Geode Capital Management LLC raised its stake in shares of UnitedHealth Group by 4.1% in the fourth quarter. Geode Capital Management LLC now owns 9,969,166 shares of the healthcare conglomerate’s stock worth $2,193,088,000 after acquiring an additional 395,090 shares during the last quarter. Finally, Alliancebernstein L.P. raised its stake in shares of UnitedHealth Group by 1.3% in the fourth quarter. Alliancebernstein L.P. now owns 7,334,593 shares of the healthcare conglomerate’s stock worth $1,616,984,000 after acquiring an additional 96,727 shares during the last quarter. 86.78% of the stock is owned by institutional investors.
A number of equities analysts have recently commented on the stock. Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 price objective for the company in a report on Saturday, January 20th. Argus raised their price objective on shares of UnitedHealth Group to $270.00 and gave the stock a “buy” rating in a report on Thursday, January 18th. Deutsche Bank raised their price objective on shares of UnitedHealth Group to $260.00 and gave the stock a “buy” rating in a report on Wednesday, January 17th. Citigroup raised their price objective on shares of UnitedHealth Group from $235.00 to $268.00 and gave the stock a “buy” rating in a report on Wednesday, January 17th. Finally, Piper Jaffray Companies reaffirmed a “buy” rating and set a $259.00 price objective on shares of UnitedHealth Group in a report on Wednesday, January 17th. Two analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the stock. The company presently has an average rating of “Buy” and a consensus target price of $244.62.
COPYRIGHT VIOLATION WARNING: This article was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are accessing this article on another website, it was illegally copied and reposted in violation of United States and international trademark and copyright law. The legal version of this article can be read at https://www.dispatchtribunal.com/2018/03/23/unitedhealth-group-inc-unh-director-richard-t-burke-sells-10000-shares.html.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.